Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2007

01-04-2007 | Preclinical Study

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-κB pathway activation as a potential mechanism of resistance

Authors: Héctor Hernández-Vargas, Socorro María Rodríguez-Pinilla, Mercedes Julián-Tendero, Pedro Sánchez-Rovira, Cristóbal Cuevas, Antonio Antón, Maria Jesus Ríos, José Palacios, Gema Moreno-Bueno

Published in: Breast Cancer Research and Treatment | Issue 2/2007

Login to get access
Metadata
Title
Gene expression profiling of breast cancer cells in response to gemcitabine: NF-κB pathway activation as a potential mechanism of resistance
Authors
Héctor Hernández-Vargas
Socorro María Rodríguez-Pinilla
Mercedes Julián-Tendero
Pedro Sánchez-Rovira
Cristóbal Cuevas
Antonio Antón
Maria Jesus Ríos
José Palacios
Gema Moreno-Bueno
Publication date
01-04-2007
Published in
Breast Cancer Research and Treatment / Issue 2/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9322-9

Other articles of this Issue 2/2007

Breast Cancer Research and Treatment 2/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine